Skip to main content

BGI, Coimbra Genomics to Study Gastric Cancer

NEW YORK (GenomeWeb News) – BGI and Portuguese startup Coimbra Genomics today announced a project to investigate the genetic basis of gastric cancer, the second most common cause of cancer after lung cancer.

The project is initially being funded with $900,000 and will involve researchers from the Institute of Molecular Pathology and Immunology at the University of Porto in Portugal, or IPATIMUP, a cancer research institute with "a particularly strong track record [in] gastric cancer," the partners said.

They said that each year there are almost 1 million new cases of gastric cancer, with the disease especially prevalent in East and Southeast Asia, as well as in Latin America, and parts of Eastern and Southern Europe.

"This collaboration forges new ties between BGI and Coimbra Genomics to share and exchange knowledge and research ideas," Yuan Liu, Europe business development director of BGI Tech, a BGI affiliate, said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.